SEARCH

SEARCH BY CITATION

References

  • Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention. (2009) Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. Morbidity and Mortality Weekly Report, 58, 10421043.
  • Arnold, D.M., Dentali, F., Crowther, M.A., Meyer, R.M., Cook, R.J., Sigouin, C., Fraser, G.A., Lim, W. & Kelton, J.G. (2007) Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Annals of Internal Medicine, 146, 2533.
  • Balz, J. & Minton, J.P. (1975) Mesenteric thrombosis following splenectomy. Annals of Surgery, 181, 126128.
  • Bisharat, N., Omari, H., Lavi, I. & Raz, R. (2001) Risk of infection and death among post-splenectomy patients. Journal of Infection, 43, 182186.
  • Bolton-Maggs, P.H.B., Stevens, R.F., Dodd, N.J., Lamont, G., Tittensor, P., King, M.J. & General Haematology Task Force of the British Committee for Standards in Haematology (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. British Journal of Haematology, 126, 455474.
  • Bourgeois, E., Caulier, M.T., Delarozee, C., Brouillard, M., Bauters, F. & Fenaux, P. (2003) Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis. British Journal of Haematology, 120, 10791088.
  • British Committee for Standards in Haematology General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology, 120, 574596.
  • Brynes, R.K., Orazi, A., Verma, S., Brainsky, A., Bailey, C.K. & Bakshi, K. (2011) Evaluation of bone marrow reticulin in patients with chronic Immune Thrombocytopenic Purpura (ITP) treated with eltrombopag – data from the EXTEND study. Blood (ASH Annual Meeting Abstracts), 118, 528.
  • Bussel, J.B., Cheng, G., Saleh, M.N., Psaila, B., Kovaleva, L., Meddeb, B., Kloczko, J., Hassani, H., Mayer, B., Stone, N.L., Arning, M., Provan, D. & Jenkins, J.M. (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New England Journal of Medicine, 357, 22372247.
  • Bussel, J.B., Provan, D., Shamsi, T., Cheng, G., Psaila, B., Kovaleva, L., Salama, A., Jenkins, J.M., Roychowdhury, D., Mayer, B., Stone, N. & Arning, M. (2009a) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet, 373, 641648.
  • Bussel, J.B., Kuter, D.J., Newland, A., de Wolf, J.T., Wasser, J., Chang, P., Nie, K. & Berger, D. (2009b) Long-term efficacy and safety of romiplostim for the treatment of patients with chronic immune thrombocytopenia (ITP): 5-year update from an open-label extension study. Blood (ASH Annual Meeting Abstracts), 114, 681.
  • Cappellini, M.D., Robbiolo, L., Bottasso, B.M., Coppola, R., Fiorelli, G. & Mannucci, A.P. (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. British Journal of Haematology, 111, 467473.
  • Cappellini, M., Cohen, A., Eleftheriou, A., Piga, A., Porter, J. & Taher, A. (Eds) (2008) Guidelines for the Clinical Management of Thalassaemia. 2nd revised edn. Thalassaemia International Federation, Nicosia, Cyprus.
  • Casaccia, M., Torelli, P., Pasa, A., Sormani, M.P. & Rossi, E. (2010) Putative predictive parameters for the outcome of laparoscopic splenectomy: a multicenter analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen. Annals of Surgery, 251, 287291.
  • Cesta, M.F. (2006) Normal structure, function, and histology of the spleen. Toxicologic Pathology, 34, 455465.
  • Chakravarty, E.F., Murray, E.R., Kelman, A. & Farmer, P. (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood, 117, 14991506.
  • Cheng, G., Saleh, M.N., Marcher, C., Vasey, S., Mayer, B., Aivado, M., Arning, M., Stone, N.L. & Bussel, J.B. (2011) Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet, 377, 393402.
  • Chung, T.C., Jeffrey, A.B., James, F.A., Robert, H.S., Patricia, J.N., Apostolos, T. & David, B.D. (1997) Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. International Journal of Radiation Oncology, Biology, Physics, 37, 405409.
  • Crary, S.E. & Buchanan, G.R. (2009) Vascular complications after splenectomy for hematologic disorders. Blood, 114, 28612868.
  • Davies, J.M., Barnes, R. & Milligan, D. (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clinical Medicine : Journal of the Royal College of Physicians of London, 2, 440443.
  • Davies, J.M., Lewis, M.P., Wimperis, J., Rafi, I., Ladhani, S. & Bolton-Maggs, P.H. (2011) Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British committee for standards in haematology by a working party of the haemato-oncology task force. British Journal of Haematology, 155, 308317.
  • Delaitre, B. & Maignien, B. (1991) Splenectomy by the laparoscopic approach. Report of a case. Presse Médicale, 20, 2263.
  • Di Sabatino, A., Carsetti, R. & Corazza, G.R. (2011) Post-splenectomy and hyposplenic states. Lancet, 378, 8697.
  • Dolan, J.P., Sheppard, B.C. & DeLoughery, T.G. (2008) Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century. American Journal of Hematology, 83, 9396.
  • Ein, S.H., Shandling, B., Simpson, J.S., Stephens, C.A., Bandi, S.K., Biggar, W.D. & Freedman, M.H. (1977) The morbidity and mortality of splenectomy in childhood. Annals of Surgery, 185, 307310.
  • Ejstrud, P., Kristensen, B., Hansen, J.B., Madsen, K.M., Schonheyder, H.C. & Sorensen, H.T. (2000) Risk and patterns of bacteraemia after splenectomy: a population-based study. Scandinavian Journal of Infectious Diseases, 32, 521525.
  • El-Alfy, M.S. & El-Sayed, M.H. (2004) Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? The Hematology Journal, 5, 7780.
  • Eldor, A. & Rachmilewitz, E.A. (2002) The hypercoagulable state in thalassemia. Blood, 99, 3643.
  • Fujita, F., Lyass, S., Otsuka, K., Giordano, L., Rosenbaum, D.L., Khalili, T.M. & Phillips, E.H. (2003) Portal vein thrombosis following splenectomy: identification of risk factors. American Surgeon, 69, 951956.
  • Gauer, J.M., Gerber-Paulet, S., Seiler, C. & Schweizer, W.P. (2008) Twenty years of splenic preservation in trauma: lower early infection rate than in splenectomy. World Journal of Surgery, 32, 27302735.
  • Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. & Colwell, C.W. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 381S453S.
  • George, J.N., Mathias, S.D., Go, R.S., Guo, M., Henry, D.H., Lyons, R., Redner, R.L., Rice, L. & Schipperus, M.R. (2009) Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. British Journal of Haematology, 144, 409415.
  • Ghantous, S., Al Mulhim, S., Al Faris, N., Abushullaih, B., Shalak, F. & Yazbeck, S. (2008) Acute chest syndrome after splenectomy in children with sickle cell disease. Journal of Pediatric Surgery, 43, 861864.
  • Gould, M.K., Garcia, D.A., Wren, S.M., Karanicolas, P.J., Arcelus, J.I., Heit, J.A. & Samama, C.M. (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th edn. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e227Se277S.
  • Green, J.B., Shackford, S.R., Sise, M.J. & Fridlund, P. (1986) Late septic complications in adults following splenectomy for trauma: a prospective analysis in 144 patients. Journal of Trauma, 26, 9991004.
  • Habermalz, B., Sauerland, S., Decker, G., Delaitre, B., Gigot, J.F., Leandros, E., Lechner, K., Rhodes, M., Silecchia, G., Szold, A., Targarona, E., Torelli, P. & Neugebauer, E. (2008) Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surgical Endoscopy, 22, 821848.
  • Hayag-Barin, J.E., Smith, R.E. & Tucker, Jr, F.C. (1998) Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. American Journal of Hematology, 57, 8284.
  • Hebbel, R.P. (2011) Reconstructing sickle cell disease: a data-based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence-based medicine. American Journal of Hematology, 86, 123154.
  • Henry-Amar, M. (1992) Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Annals of Oncology, 3Suppl. 4, 117128.
  • Heuer, M., Taeger, G., Kaiser, G.M., Nast-Kolb, D., Kuhne, C.A., Ruchholtz, S., Lefering, R., Paul, A. & Lendemans, S. (2010) No further incidence of sepsis after splenectomy for severe trauma: a multi-institutional experience of The trauma registry of the DGU with 1,630 patients. European Journal of Medical Research, 15, 258265.
  • Ikeda, M., Sekimoto, M., Takiguchi, S., Kubota, M., Ikenaga, M., Yamamoto, H., Fujiwara, Y., Ohue, M., Yasuda, T., Imamura, H., Tatsuta, M., Yano, M., Furukawa, H. & Monden, M. (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Annals of Surgery, 241, 208216.
  • Jia, T. & Pamer, E.G. (2009) Immunology. Dispensable but not irrelevant. Science, 325, 549550.
  • Kaldor, J.M., Day, N.E., Pettersson, F., Clarke, E.A., Pedersen, D., Mehnert, W., Bell, J., Høst, H., Prior, P., Karjalainen, S., Neal, F., Koch, M., Band, P., Choi, W., Pompe Kirn, V., Arslan, A., Zarén, B., Belch, A.R., Storm, H., Kittelmann, B., Fraser, P. & Stovall, M. (1990) Leukemia following chemotherapy for ovarian cancer. New England Journal of Medicine, 322, 16.
  • Kalpatthi, R., Kane, I.D., Shatat, I.F., Rackoff, B., Disco, D. & Jackson, S.M. (2010) Clinical events after surgical splenectomy in children with sickle cell anemia. Pediatric Surgery International, 26, 495500.
  • Kato, G.J. (2009) Vascular complications after splenectomy for hematologic disorders. Blood, 114, 54045404.
  • Keidar, A., Feldman, M. & Szold, A. (2005) Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet count. American Journal of Hematology, 80, 95100.
  • King, H. & Shumacker, Jr, H.B. (1952) Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Annals of Surgery, 136, 239242.
  • Kojouri, K., Vesely, S.K., Terrell, D.R. & George, J.N. (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood, 104, 26232634.
  • Kokoska, E.R., West, K.W., Carney, D.E., Engum, S.E., Heiny, M.E. & Rescorla, F.J. (2004) Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery. Journal of Pediatric Surgery, 39, 848850.
  • Krauth, M.-T., Lechner, K., Neugebauer, E.A.M. & Pabinger, I. (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention – an unresolved issue. Haematologica, 93, 12271232.
  • Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, Jr, T.H., Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrere, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M. & Nichol, J.L. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet, 371, 395403.
  • Kuter, D.J., Mufti, G.J., Bain, B.J., Hasserjian, R.P., Davis, W. & Rutstein, M. (2009) Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia (ITP) patients treated with romiplostim. Blood, 114, 37483756.
  • Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010a) Romiplostim or standard of care in patients with immune thrombocytopenia. New England Journal of Medicine, 363, 18891899.
  • Kuter, D.J., Bussel, J.B., Newland, A., Wasser, J.S., Lyons, R.M., George, J.N., Macik, G., Nie, K. & Jun, S. (2010b) Long-term efficacy and safety of romiplostim treatment of adult patients with chronic immune thrombocytopenia (ITP): final report from an open-label extension study. Blood (ASH Annual Meeting Abstracts), 116, 68.
  • Kuter, D.J., Mathias, S.D., Rummel, M., Mandanas, R., Giagounidis, A.A., Wang, X. & Deuson, R.R. (2012) Health-related quality of life in non-splenectomised immune thrombocytopenia (ITP) patients receiving romiplostim or medical standard of care. American Journal of Hematology, 87, 558561.
  • Langley, J., Dodds, L., Fell, D. & Langley, G.R. (2010) Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990–2002. BMC Infectious Diseases, 10, 219.
  • Lechner, K. & Jager, U. (2010) How I treat autoimmune hemolytic anemias in adults. Blood, 116, 18311838.
  • van Leeuwen, F.E., Somers, R. & Hart, A.A. (1987) Splenectomy in Hodgkin's disease and second leukaemias. Lancet, 2, 210211.
  • Linet, M.S., Nyren, O., Gridley, G., Mellemkjaer, L., McLaughlin, J.K., Olsen, J.H., Adami, H.O. & Fraumeni, Jr, J.F. (1996) Risk of cancer following splenectomy. International Journal of Cancer, 66, 611616.
  • Makris, M., Greaves, M., Winfield, D.A., Preston, F.E. & Lilleyman, J.S. (1994) Long-term management after splenectomy. Lifelong penicillin unproved in trials. British Medical Journal, 308, 131132.
  • Mannucci, P.M. (2010) Red cells playing as activated platelets in thalassemia intermedia. Journal of Thrombosis and Haemostasis, 8, 21492151.
  • Mazzucconi, M.G., Arista, M.C., Peraino, M., Chistolini, A., Felici, C., Francavilla, V., Macale, E., Conti, L. & Gandolfo, G.M. (1999) Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. European Journal of Haematology, 62, 219222.
  • McMillan, R. & Durette, C. (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood, 104, 956960.
  • Mebius, R.E. & Kraal, G. (2005) Structure and function of the spleen. Nature Reviews Immunology, 5, 606616.
  • Mellemkjoer, L., Olsen, J.H., Linet, M.S., Gridley, G. & McLaughlin, J.K. (1995) Cancer risk after splenectomy. Cancer, 75, 577583.
  • Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L. & Crowther, M.A. (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood, 117, 41904207.
  • Neylon, A.J., Saunders, P.W., Howard, M.R., Proctor, S.J. & Taylor, P.R. (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. British Journal of Haematology, 122, 966974.
  • Okabayashi, T. & Hanazaki, K. (2008) Overwhelming postsplenectomy infection syndrome in adults – a clinically preventable disease. World Journal of Gastroenterology, 14, 176179.
  • Park, M.A., Li, J.T., Hagan, J.B., Maddox, D.E. & Abraham, R.S. (2008) Common variable immunodeficiency: a new look at an old disease. Lancet, 372, 489502.
  • Patel, V., Mihatov, N., Cooper, N., Stasi, R., Cunningham-Rundles, S. & Bussel, J.B. (2006) Long term follow-up of patients with immune thrombocytopenic purpura (ITP) whose initial response to rituximab lasted a minimum of 1 year. Blood (ASH Annual Meeting Abstracts), 108, 479.
  • Portielje, J.E., Westendorp, R.G., Kluin-Nelemans, H.C. & Brand, A. (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood, 97, 25492554.
  • Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168186.
  • van't Riet, M., Burger, J.W., van Muiswinkel, J.M., Kazemier, G., Schipperus, M.R. & Bonjer, H.J. (2000) Diagnosis and treatment of portal vein thrombosis following splenectomy. British Journal of Surgery, 87, 12291233.
  • Robinette, C.D. & Fraumeni, Jr, J.F. (1977) Splenectomy and subsequent mortality in veterans of the 1939–45 war. Lancet, 2, 127129.
  • Rodeghiero, F. & Ruggeri, M. (2008) Is splenectomy still the gold standard for the treatment of chronic ITP? American Journal of Hematology, 83, 91.
  • Rodeghiero, F. & Ruggeri, M. (2011) Idiopathic thrombocytopenic purpura. http://bestpractice.bmj.com/best-practice/monograph/138.html.
  • Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kuhne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children: report from an international working group. Blood, 113, 23862393.
  • Saleh, M.N., Bussel, J.B., Meyer, O., Frederiksen, H., Johnni, D., Aivado, M. & Brainsky, A. (2009) Results of bone marrow examinations in patients with chronic immune thrombocytopenic purpura treated with eltrombopag. Blood (ASH Annual Meeting Abstracts), 114, 1326.
  • Sanz, M.A., Aledort, L., Mathias, S.D., Wang, X. & Isitt, J.J. (2011) Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP). Value in Health, 14, 9096.
  • Schilling, R.F. (1997) Spherocytosis, splenectomy, strokes, and heat attacks. Lancet, 350, 16771678.
  • Schilling, R.F. (2009) Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis–a personal view. British Journal of Haematology, 145, 728732.
  • Schwartz, P.E., Sterioff, S., Mucha, P., Melton, III, L.J. & Offord, K.P. (1982) Postsplenectomy sepsis and mortality in adults. JAMA, 248, 22792283.
  • Schwartz, J., Leber, M.D., Gillis, S., Giunta, A., Eldor, A. & Bussel, J.B. (2003) Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). American Journal of Hematology, 72, 9498.
  • Stamou, K.M., Toutouzas, K.G., Kekis, P.B., Nakos, S., Gafou, A., Manouras, A., Krespis, E., Katsaragakis, S. & Bramis, J. (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Archives of Surgery, 141, 663669.
  • Stasi, R., Stipa, E., Masi, M., Cecconi, M., Scimo, M.T., Oliva, F., Sciarra, A., Perrotti, A.P., Adomo, G., Amadori, S. & Papa, G. (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. American Journal of Medicine, 98, 436442.
  • Stasi, R., Newland, A., Thornton, P. & Pabinger, I. (2010) Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate. Annals of Hematology, 89, 11851195.
  • Steinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. & Terrin, M. (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA, 289, 16451651.
  • Steinberg, M.H., McCarthy, W.F., Castro, O., Ballas, S.K., Armstrong, F.D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L. & Waclawiw, M.A. (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. American Journal of Hematology, 85, 403408.
  • Swirski, F.K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R.H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T.R., Libby, P., Weissleder, R. & Pittet, M.J. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science, 325, 612616.
  • Taher, A., Isma'eel, H., Mehio, G., Bignamini, D., Kattamis, A., Rachmilewitz, E.A. & Cappellini, M.D. (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thrombosis and Haemostasis, 96, 488491.
  • Taher, A.T., Musallam, K.M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.S., El-Chafic, A.H., Fasulo, M.R. & Cappellini, M.D. (2010a) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood, 115, 18861892.
  • Taher, A.T., Musallam, K.M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M., Cesaretti, C. & Cappellini, M.D. (2010b) Splenectomy and thrombosis: the case of thalassemia intermedia. Journal of Thrombosis and Haemostasis, 8, 21522158.
  • Targarona, E.M. (2008) Portal vein thrombosis after laparoscopic splenectomy: the size of the risk. Surgical Innovation, 15, 266270.
  • Tavazzi, D., Duca, L., Graziadei, G., Comino, A., Fiorelli, G. & Cappellini, M.D. (2001) Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes. British Journal of Haematology, 112, 4850.
  • Thomsen, R.W., Schoonen, W.M., Farkas, D.r.K., Riis, A., Jacobsen, J., Fryzek, J.P. & SÃ,Rensen, H.T. (2009) Risk for hospital contact with infection in patients with splenectomy. Annals of Internal Medicine, 151, 546555.
  • Thomsen, R.W., Schoonen, W.M., Farkas, D.K., Riis, A., Fryzek, J.P. & SØRensen, H.T. (2010) Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. Journal of Thrombosis and Haemostasis, 8, 14131416.
  • Tso, S.C., Chan, T.K. & Todd, D. (1982) Venous thrombosis in haemoglobin H disease after splenectomy. Australian and New Zealand Journal of Medicine, 12, 635638.
  • Tura, S., Fiacchini, M., Zinzani, P.L., Brusamolino, E. & Gobbi, P.G. (1993) Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. Journal of Clinical Oncology, 11, 925930.
  • Vianelli, N., Galli, M., de Vivo, A., Intermesoli, T., Giannini, B., Mazzucconi, M.G., Barbui, T., Tura, S. & Baccaranion, M. (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica, 90, 7277.
  • Wang, H., Kopac, D., Brisebois, R., Sample, C. & Shapiro, A.M. (2011) Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy. Canadian Journal of Surgery, 54, 227231.
  • White, D.J., Talarico, J., Chang, H.G., Birkhead, G.S., Heimberger, T. & Morse, D.L. (1998) Human babesiosis in New York state: review of 139 hospitalized cases and analysis of prognostic factors. Archives of Internal Medicine, 158, 21492154.
  • Winslow, E.R. & Brunt, L.M. (2003) Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery, 134, 647653; discussion 654–655.
  • Wright, J.G., Hambleton, I.R., Thomas, P.W., Duncan, N.D., Venugopal, S. & Serjeant, G.R. (1999) Postsplenectomy course in homozygous sickle cell disease. Journal of Pediatrics, 134, 304309.
  • Yong, M., Thomsen, R.W., Schoonen, W.M., Farkas, D.K., Riis, A., Fryzek, J.P. & Sørensen, H.T. (2010) Mortality risk in splenectomised patients: a Danish population-based cohort study. European Journal of Internal Medicine, 21, 1216.
  • Yri, O.E., Torfoss, D., Hungnes, O., Tierens, A., Waalen, K., Nordoy, T., Dudman, S., Kilander, A., Wader, K.F., Ostenstad, B., Ekanger, R., Meyer, P. & Kolstad, A. (2011) Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood, 118, 67696771.